Literature DB >> 17257229

Primary and secondary red ear syndrome: implications for treatment.

P Boulton1, R A Purdy, E P Bosch, D W Dodick.   

Abstract

Approximately 57 patients with red ear syndrome have been reported in the literature since it was initially described in 1994. The clinical phenotype therefore continues to be defined and no consistent treatment response has been described. We report three new cases of red ear syndrome and suggest that the disorder may exist as a primary trigeminal or cervical autonomic cephalalgia, coexist with other rare trigeminal autonomic cephalalgias, or may be secondary. The pathogenesis in these different circumstances may be distinct, the triggers specific and, when secondary, the disorder may be more resistant to treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17257229     DOI: 10.1111/j.1468-2982.2007.01270.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  6 in total

Review 1.  Red Ear Syndrome.

Authors:  V Raieli; A Compagno; M D'Amelio
Journal:  Curr Pain Headache Rep       Date:  2016-03

Review 2.  Red ear syndrome.

Authors:  R Allan Purdy; David W Dodick
Journal:  Curr Pain Headache Rep       Date:  2007-08

3.  The Almirall European Headache Awards 2009.

Authors:  Daniela Grimaldi; Sónia Batista; Alice Poisson; Hanne-Laure Verschelde; Fernando Vázquez-Sánchez
Journal:  J Headache Pain       Date:  2010-04-06       Impact factor: 7.277

Review 4.  The red ear syndrome.

Authors:  Giorgio Lambru; Sarah Miller; Manjit S Matharu
Journal:  J Headache Pain       Date:  2013-10-04       Impact factor: 7.277

5.  Red ear syndrome precipitated by a dietary trigger: a case report.

Authors:  Chung Chi Chan; Susmita Ghosh
Journal:  J Med Case Rep       Date:  2014-10-10

6.  Red Ear Syndrome: Case Series and Review of a Less Recognized Headache Disorder.

Authors:  Ishani Patel; Devangi Desai; Soaham Desai
Journal:  Ann Indian Acad Neurol       Date:  2020-04-07       Impact factor: 1.383

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.